PA

Perceptive Advisors Portfolio holdings

AUM $2.67B
This Quarter Return
-2.06%
1 Year Return
+73.17%
3 Year Return
+837.18%
5 Year Return
+928.4%
10 Year Return
+11,818.45%
AUM
$6.47B
AUM Growth
+$6.47B
Cap. Flow
+$389M
Cap. Flow %
6.02%
Top 10 Hldgs %
43.26%
Holding
162
New
22
Increased
15
Reduced
43
Closed
15

Top Buys

1
LIAN
LianBio American Depositary Shares
LIAN
$347M
2
BMRN icon
BioMarin Pharmaceuticals
BMRN
$104M
3
BLU
BELLUS Health Inc.
BLU
$61.5M
4
ARNA
Arena Pharmaceuticals Inc
ARNA
$46.5M
5
APLS icon
Apellis Pharmaceuticals
APLS
$39.6M

Top Sells

1
AVIR icon
Atea Pharmaceuticals
AVIR
$79.2M
2
BEAM icon
Beam Therapeutics
BEAM
$46.8M
3
DBVT
DBV Technologies
DBVT
$37.7M
4
NVTA
Invitae Corporation
NVTA
$35.7M
5
GBT
Global Blood Therapeutics, Inc.
GBT
$28M

Sector Composition

1 Healthcare 85.17%
2 Financials 0.38%
3 Industrials 0.09%
4 Consumer Discretionary 0.02%
Name Market Value Portfolio Weight Shares or Principal Shares
Change % 		Capital Flow
MRTX
1
DELISTED
Mirati Therapeutics, Inc. Common Stock
MRTX
$482M 7.42% 3,283,783 -103,962 -3% -$15.3M
LIAN
2
DELISTED
LianBio American Depositary Shares
LIAN
$347M 5.35% +56,319,960 New +$347M
FOLD icon
3
Amicus Therapeutics
FOLD
$2.34B
$307M 4.73% 26,559,443 – –
SWTX
4
DELISTED
SpringWorks Therapeutics
SWTX
$301M 4.63% 4,849,912 – –
IOVA icon
5
Iovance Biotherapeutics
IOVA
$807M
$193M 2.98% 10,127,941 -1,361,831 -12% -$26M
HZNP
6
DELISTED
Horizon Therapeutics Public Limited Company Ordinary Shares
HZNP
$187M 2.89% 1,738,140 -218,800 -11% -$23.6M
MGTX icon
7
MeiraGTx Holdings
MGTX
$587M
$165M 2.54% 6,948,277 – –
CERE
8
DELISTED
Cerevel Therapeutics Holdings, Inc. Common Stock
CERE
$165M 2.54% 5,086,727 – –
CRNX icon
9
Crinetics Pharmaceuticals
CRNX
$2.92B
$147M 2.26% 5,163,517 +1,200,000 +30% +$34.1M
RXDX
10
DELISTED
Prometheus Biosciences, Inc. Common Stock
RXDX
$125M 1.93% 3,172,785 -141,247 -4% -$5.58M
VBIV
11
DELISTED
VBI Vaccines, Inc. New Common Stock (Canada)
VBIV
$122M 1.89% 52,335,002 -2,707,463 -5% -$6.34M
BBIO icon
12
BridgeBio Pharma
BBIO
$9.89B
$119M 1.83% 7,128,755 -628,173 -8% -$10.5M
ISEE
13
DELISTED
IVERIC bio, Inc. Common Stock
ISEE
$108M 1.67% 6,480,000 -991,798 -13% -$16.6M
RAPT icon
14
RAPT Therapeutics
RAPT
$188M
$108M 1.66% 2,927,565 +20,000 +0.7% +$735K
BMRN icon
15
BioMarin Pharmaceuticals
BMRN
$11.2B
$104M 1.61% +1,180,000 New +$104M
GBT
16
DELISTED
Global Blood Therapeutics, Inc.
GBT
$101M 1.56% 3,449,915 -957,484 -22% -$28M
CHRS icon
17
Coherus Oncology, Inc. Common Stock
CHRS
$135M
$86.3M 1.33% 5,407,798 +628,411 +13% +$10M
OM icon
18
Outset Medical
OM
$247M
$85.9M 1.32% 1,863,397 -127,236 -6% -$5.86M
XENE icon
19
Xenon Pharmaceuticals
XENE
$2.98B
$75.3M 1.16% 2,411,447 +389,396 +19% +$12.2M
LABP
20
DELISTED
Landos Biopharma, Inc. Common Stock
LABP
$71.4M 1.1% 14,869,915 – –
CCCC icon
21
C4 Therapeutics
CCCC
$185M
$71.1M 1.1% 2,208,913 -49,653 -2% -$1.6M
APLS icon
22
Apellis Pharmaceuticals
APLS
$3.48B
$68.6M 1.06% 1,451,700 +836,700 +136% +$39.6M
BLU
23
DELISTED
BELLUS Health Inc.
BLU
$61.5M 0.95% +7,645,234 New +$61.5M
ZYME icon
24
Zymeworks
ZYME
$1.12B
$60.3M 0.93% 3,679,845 – –
RLAY icon
25
Relay Therapeutics
RLAY
$619M
$59.7M 0.92% 1,943,097 – –
1
2 3 4 5